Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 19,998 | 15,770 | 12,679 | 9,732 | 10,772 |
| Operating Income | -19,998 | -15,770 | -12,679 | -9,732 | -10,772 |
| Interest Expense | 63 | 64 | 43 | 64 | 70 |
| Other Income | 1,192 | -1,027 | 58,168 | -318 | 5,645 |
| Pre-tax Income | -18,869 | -16,861 | 45,446 | -10,114 | -5,197 |
| Net Income Continuous | -18,869 | -16,861 | 45,446 | -10,114 | -5,197 |
| Net Income | $-18,869 | $-16,861 | $45,446 | $-10,114 | $-5,197 |
| EPS Basic Total Ops | -0.35 | 1.37 | 0.50 | -1.09 | -0.56 |
| EPS Basic Continuous Ops | -0.35 | -1.93 | 4.26 | -1.09 | -0.56 |
| EPS Diluted Total Ops | -0.35 | 1.07 | -0.21 | -1.09 | -0.56 |
| EPS Diluted Continuous Ops | -0.35 | 1.28 | 0.58 | -1.09 | -0.56 |
| EPS Diluted Before Non-Recurring Items | -0.35 | -0.46 | -0.21 | -1.09 | -0.56 |
| EBITDA(a) | $-19,235 | $-15,044 | $-11,937 | $-8,966 | $-10,013 |